• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Why ODs should treat dry eye

Optometry Times JournalJanuary Digital Edition 2020
Volume 12
Issue 1

The condition is everywhere, and your patients need you.

Dry eye is a topic eliciting much discussion among our colleagues. Many of us dive headlong into the topic. There has been an explosion of information about the condition in the last decade, every continuing education meeting has several presentations on the subject, and a cottage industry has sprung up concerning diagnosis and management of the disease.

For good reason. What was once considered an afterthought in our practices has been shown to be ubiquitous and has become an inevitable public health problem.

Related: Dr. Ernie Bowling discusses dry eye in the digital age

Common and costly

Dry eye is one of the most common ophthalmic conditions, affecting hundreds of millions of people worldwide. Dry eye affects five percent to 30 percent of the world population 50 years and older, with women representing approximately two-thirds of those affected.1 The disease is increasing in younger patients.

Dry eye has a significant impact on quality of life due to chronic symptoms of ocular pain and discomfort in addition to functional vision impairment. Dry eye can impact functional vision, interfering with everyday activities such as driving, reading, computer usage, watching television, and work performance.2 Dry eye negatively impacts mental health as dry eye patients report higher rates of anxiety and depression.3

Dry eye disease is among the most common reasons for visiting eye care practitioners and represents a substantial health and cost burden.Financially, dry eye is estimated to cost $3.84 billion per year to the healthcare system with an average annual cost of $783 per patient for treatment.4

Related: Lactoferrin levels can diagnose dry eye disease

Where to start

So, it is obvious that a lot of patients are suffering with dry eye. Dry eye is everywhere, going undiagnosed/underdiagnosed/undertreated, and our patients need our help. It is in our patients’ best interests to properly recognize and treat the condition.

Still, with the abundance of information available, it is easy for one to be overwhelmed with the data available. Where to start? How do I start? Do I really need all the bells and whistles available in the marketplace to properly diagnose and treat dry eye?

More to come

Which is where this project comes in. Over the course of the next year, we will explore developing a dry eye subspecialty within your practice. We will cover the nuts and bolts of starting a dry eye clinic, using the knowledge from experienced practitioners who have done just that in their practices. We aim to provide information on where to start, how to start, and some of the pitfalls and missteps along the way so you can avoid those stumbles.

Dry eye is a great practice builder. It is an excellent entry point into medical optometric care. You can spend as much or as little as you like, based on your budget and desire, to develop your dry eye practice.

Even more importantly, you’ll be providing a much-needed service to the scores of patients in your practice who are suffering from dry eye overtly or in silence. Your patients will thank you for recognizing their problem and addressing their needs. And who knows? You may have fun along the journey.

More by Dr. Bowling: Good news is out there during COVID-19


1. Stapleton F, Alves M, Bunya VY, Jalbert, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017 Jul;15(3):334-365.

2. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007 Mar;143(3):409-15.

3. Li M, Gong L, Sun X, Chapin WJ. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011 Jan;36(1):1-7.

4. McDonald M, Patel DA, Keith MS, Snedecor SJ. Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review. Ocul Surf. 2016 Apr;14(2):144-167.

Related Videos
Megan Cavet, PhD
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times about the benefits of Vevye in the treatment of dry eye
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
© 2024 MJH Life Sciences

All rights reserved.